Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Phase 2 Study to Evaluate the Efficacy & Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients With Head & Neck Cancer Receiving Chemoradiation

The trial is designed to treat subjects in the trial for 7 weeks.

Th secondary outcomes are to show the duration of oral mucositis and the time it takes for brilacidin treatment to reduce the grade during treatment and to monitor whether the effects last fro 4 more weeks even after completing 7 weeks of thrice daily treatment with Brilacidin.

https://clinicaltrials.gov/ct2/show/NCT02324335?term=cellceutix&rank=3

Good luck and GOD bless,

George